Zobrazeno 1 - 10
of 68
pro vyhledávání: '"A E, Sluder"'
Publikováno v:
BioTechniques, Pp 1-10 (2024)
Avidin-biotin binding, the most robust non-covalent protein-ligand interaction occurring in nature, has wide-ranging applications in biotechnology. A frequent challenge in these applications is accurately determining the number of unoccupied biotin b
Externí odkaz:
https://doaj.org/article/c3a988544e4e41a998d75a6da60b4f19
Publikováno v:
FASEB BioAdvances, Vol 5, Iss 7, Pp 287-304 (2023)
Abstract While progress has been made in the development of islet cell transplantation (ICT) as a viable alternative to the use of exogenous insulin therapy in the treatment of type 1 diabetes, it has not yet achieved its full potential in clinical s
Externí odkaz:
https://doaj.org/article/2bdb267a328a4fdfb1803e2ab0e3604b
Autor:
Mark C Poznansky, Paul Korner, Yohannes Gemechu, Sonia Mukherjee, Jeffrey A Gelfand, Timothy A Brauns, Ann E Sluder, Pierre R Leblanc, George Steinfels, Ishan Kapila, Zachary Shriver, Patrick M Reeves
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/24adf778a0e345878e431e8e452c5364
Autor:
Susan Raju Paul, Ivan Valiev, Skylar E. Korek, Vladimir Zyrin, Diana Shamsutdinova, Olga Gancharova, Alexander Zaitsev, Ekaterina Nuzhdina, Diane L. Davies, Ibiayi Dagogo‐Jack, Felix Frenkel, Jessica H. Brown, Joshua M. Hess, Sarah Viet, Jason L. Petersen, Cameron D. Wright, Harald C. Ott, Hugh G. Auchincloss, Ashok Muniappan, Toshihiro Shioda, Michael Lanuti, Christel M. Davis, Erik A. Ehli, Yin P. Hung, Mari Mino‐Kenudson, Maria Tsiper, Ann E. Sluder, Patrick M. Reeves, Nikita Kotlov, Alexander Bagaev, Ravshan Ataullakhanov, Mark C. Poznansky
Publikováno v:
FASEB BioAdvances, Vol 5, Iss 4, Pp 156-170 (2023)
Abstract Lung cancer is the leading cause of cancer‐related deaths worldwide. Surgery and chemoradiation are the standard of care in early stages of non‐small cell lung cancer (NSCLC), while immunotherapy is the standard of care in late‐stage N
Externí odkaz:
https://doaj.org/article/2fdae20227e943d885e32ad85125e390
Autor:
Susan Raju Paul, Anja Scholzen, Patrick M. Reeves, Robert Shepard, Joshua M. Hess, Richard K. Dzeng, Skylar Korek, Anja Garritsen, Mark C. Poznansky, Ann E. Sluder
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionQ fever, caused by the intracellular bacterium Coxiella burnetii, is considered an occupational and biodefense hazard and can result in debilitating long-term complications. While natural infection and vaccination induce humoral and cellu
Externí odkaz:
https://doaj.org/article/a865dc2f7c6c4ffc86c89c87f974b560
Autor:
Susan Raju Paul, Anja Scholzen, Ghazel Mukhtar, Stephanie Wilkinson, Peter Hobson, Richard K. Dzeng, Jennifer Evans, Jennifer Robson, Rowland Cobbold, Stephen Graves, Mark C. Poznansky, Anja Garritsen, Ann E. Sluder
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Q fever is a zoonotic disease caused by the highly infectious Gram-negative coccobacillus, Coxiella burnetii (C. burnetii). The Q fever vaccine Q-VAX® is characterised by high reactogenicity, requiring individuals to be pre-screened for prior exposu
Externí odkaz:
https://doaj.org/article/8c6d90f2d21149eebb96ec52a13cd52f
Autor:
Ann E. Sluder, Susan Raju Paul, Leonard Moise, Christina Dold, Guilhem Richard, Laura Silva-Reyes, Laurie A. Baeten, Anja Scholzen, Patrick M. Reeves, Andrew J. Pollard, Anja Garritsen, Richard A. Bowen, Anne S. De Groot, Christine Rollier, Mark C. Poznansky
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
T cell-mediated immunity plays a central role in the control and clearance of intracellular Coxiella burnetii infection, which can cause Q fever. Therefore, we aimed to develop a novel T cell-targeted vaccine that induces pathogen-specific cell-media
Externí odkaz:
https://doaj.org/article/0a5ff63337eb4ed29ed7e0c1c90e73b2
Autor:
Anja Scholzen, Margot de Vries, Hans-Peter Duerr, Hendrik-Jan Roest, Ann E. Sluder, Mark C. Poznansky, Milou L. C. E. Kouwijzer, Anja Garritsen
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
For the zoonotic disease Q fever, serological analysis plays a dominant role in the diagnosis of Coxiella burnetii infection and in pre-screening for past exposure prior to vaccination. A number of studies suggest that assessment of C. burnetii-speci
Externí odkaz:
https://doaj.org/article/a5b0d4ee1bb94f2fa47600445d302a25
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 12, Pp 2977-2981 (2017)
Development of vaccines that are both safe and effective remains a costly and time-consuming challenge. To accelerate the pace of development and improve the efficacy and safety of candidate vaccines for both existing and emerging infectious agents,
Externí odkaz:
https://doaj.org/article/f2af63f347864d6e946229fbd4664870
Autor:
Anja Scholzen, Guilhem Richard, Leonard Moise, Laurie A. Baeten, Patrick M. Reeves, William D. Martin, Timothy A. Brauns, Christine M. Boyle, Susan Raju Paul, Richard Bucala, Richard A. Bowen, Anja Garritsen, Anne S. De Groot, Ann E. Sluder, Mark C. Poznansky
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Coxiella burnetii, the causative agent of Q fever, is a Gram-negative intracellular bacterium transmitted via aerosol. Regulatory approval of the Australian whole-cell vaccine Q-VAX® in the US and Europe is hindered by reactogenicity in previously e
Externí odkaz:
https://doaj.org/article/8f3d7cea8fe147daa18cf4076819e78a